Table 1 Characteristics of the study population.

From: Evaluation of core Biomarkers of Alzheimer’s disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform

Variable

Nr

42

Sex, M/F

21/21

Age, yrs

67.50 [10.75]

Disease, nr

 Alzheimer’s disease

27

 Conversion disorder

1

 Other dementia

14

Biomarkers levels, median [IQR]

 CSF

  Aβ40, pg/mL

8620 [3266.00]

  Aβ42, pg/mL

444.0 [267.20]

  Aβ42/40 ratio

0.049 [0.03]

  pTau, pg/mL

76.00 [89.80]

  pTau/Aβ42

0.20 [0.28]

 Plasma

  Aβ40, pg/mL

270.9 [44.30]

  Aβ42, pg/mL

26.05 [7.25]

  Aβ42/40 ratio

0.098 [0.01]

  pTau, pg/mL

1.79 [1.25]

  pTau/Aβ42

0.07 [0.05]

 Saliva

  Aβ40, pg/mL

0.70 [1.19]

  Aβ42, pg/mL

0.61 [1.37]

  Aβ42/40 ratio

0.775 [0.68]

  pTau, pg/mL

5.58 [6.66]

  pTau/Aβ42

6.30 [14.94]